CITIGROUP INC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 80 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$59
-94.1%
107
-91.1%
0.00%
Q3 2022$1,000
-66.7%
1,206
-71.4%
0.00%
Q2 2022$3,000
-50.0%
4,221
-18.1%
0.00%
Q1 2022$6,000
-89.3%
5,152
-79.2%
0.00%
Q4 2021$56,000
+64.7%
24,773
+145.9%
0.00%
Q3 2021$34,000
+183.3%
10,073
+141.7%
0.00%
Q2 2021$12,000
-75.0%
4,167
-71.7%
0.00%
Q1 2021$48,000
+128.6%
14,716
+125.8%
0.00%
Q1 2017$21,000
-72.4%
6,517
-88.3%
0.00%
Q4 2016$76,000
+162.1%
55,799
+198.7%
0.00%
Q3 2016$29,000
+222.2%
18,679
+188.7%
0.00%
Q2 2016$9,000
-95.3%
6,469
-82.0%
0.00%
Q1 2016$190,000
+211.5%
36,001
+357.3%
0.00%
Q4 2015$61,000
-89.6%
7,873
-88.7%
0.00%
-100.0%
Q3 2015$589,000
+435.5%
69,762
+593.0%
0.00%
Q2 2015$110,000
-50.0%
10,066
-36.3%
0.00%
Q1 2015$220,000
-37.0%
15,791
-23.6%
0.00%
Q4 2014$349,000
+571.2%
20,670
+429.2%
0.00%
Q3 2014$52,000
-28.8%
3,906
-31.6%
0.00%
Q2 2014$73,000
-66.8%
5,713
-69.1%
0.00%
Q1 2014$220,000
-22.5%
18,514
-9.9%
0.00%
Q4 2013$284,000
-58.8%
20,537
-48.0%
0.00%
-100.0%
Q3 2013$689,000
+28.1%
39,486
+19.2%
0.00%0.0%
Q2 2013$538,00033,1390.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$4,017,0000.19%
Gratus Capital, LLC 1,117,154$706,0000.08%
Bleichroeder LP 250,000$158,0000.03%
Polar Capital Holdings Plc 5,000,000$3,162,0000.02%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$345,0000.01%
Ergoteles LLC 419,652$265,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 249,000$157,0000.00%
Y-Intercept (Hong Kong) Ltd 41,396$26,0000.00%
Heritage Financial Services, LLC 4,749$3,0000.00%
Evercore Wealth Management, LLC 143,138$91,0000.00%
View complete list of INFINITY PHARMACEUTICALS INC shareholders